HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES


Losing Stock Guy: Why He Went Wrong

By Kevin Matras
Quote:
Login Free Membership
Search:

 
Timely Buy of the Week

Perrigo Company

October 30, 2008 | Comments: 0
Recommended this article (0)
Print    Share
Perrigo Company (PRGO - Snapshot Report) is in one of the sectors that investors have been flocking to during the market downturn: health care.

The company, a Zacks #1 Rank (strong buy), which manufactures and distributes over-the-counter (OTC) and prescription pharmaceuticals, nutritional products and consumer products, is expanding as consumers switch from more expensive, brand-name products to cheaper items in a slowing economy.

Perrigo is one of the largest suppliers of branded products to retailers. It supplies products in more than 15 categories and 500 formulas and offers analgesics, cough and cold remedies, and gastrointestinal and feminine hygiene products, as well as vitamins, dietary supplements and nutritional drinks.

Perrigo Gets Tentative Approval for Ibuprofen PM

Perrigo continues to invest in new generic products. On Oct 29, PRGO announced it received tentative approval from the FDA for its over-the-counter Ibuprofen and Diphenhydramine Citrate Tablets, 200/38 mg., which is a pain reliever/nighttime sleep aid.

The company estimates that brand sales for the product for the prior 12 months ending Sept 30, 2008 were $70 million.

Perrigo is a Value Stock

Analysts continue to be bullish about Perrigo's future. 2008 year-over-year growth is expected to be 24.05%.

Full year 2009 estimates are up 4 cents to $1.96 in the last 60 days. Estimates for the first-quarter 2009 are up 2 cents to 42 cents in the last 30 days.

Perrigo has a forward P/E of 14.8. Its price-to-book is 3.0. PRGO has a stellar 1-year return on equity (ROE) of 17.5%.

The company has surprised on earnings 3 out of 4 quarters by an average of 11.65%. It reports first-quarter 2009 earnings on Nov 6.


Email

Print

Share

RSS

Rate Pos

Rate Neg

Comment
Read/Post Comments (0) | Recommended this article (0)
 Posting Comment...
There was a problem posting this this comment. Please try back later.
[CLICK TO CLOSE X]
Comments (Limit 1000 Characters - Used: 0)
Display Name: Email Address:  
 Loading Comments...
Be the first to comment on this article!

More Zacks Resources

Market Summary Nov 24, 2009 18:12 pm ET
DJIA 10433.71  -17.24 -0.16%
NASD 2169.18  -6.83 -0.31%
S&P 500 1105.65  -0.59 -0.05%
Sponsored Links